BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19786737)

  • 1. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1.
    Meyers KE; Christensen M; Madaio MP
    Am J Nephrol; 2009; 30(5):474-80. PubMed ID: 19786737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human antiglomerular basement membrane autoantibody disease in XenoMouse II.
    Meyers KE; Allen J; Gehret J; Jacobovits A; Gallo M; Neilson EG; Hopfer H; Kalluri R; Madaio MP
    Kidney Int; 2002 May; 61(5):1666-73. PubMed ID: 11967016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
    Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
    Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
    Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
    Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants.
    Meyers KE; Kinniry PA; Kalluri R; Neilson EG; Madaio MP
    Kidney Int; 1998 Feb; 53(2):402-7. PubMed ID: 9461099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB; Hudson BG
    Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
    Kalluri R; Sun MJ; Hudson BG; Neilson EG
    J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
    MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
    Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers.
    Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB
    J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
    Borza DB; Netzer KO; Leinonen A; Todd P; Cervera J; Saus J; Hudson BG
    J Biol Chem; 2000 Feb; 275(8):6030-7. PubMed ID: 10681598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
    Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
    Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
    Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
    Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine Ig light chain transgene reveals IGKV3 gene contributions to anti-collagen types IV and II specificities.
    Clark AG; Worni-Schudel IM; Korte FM; Foster MH
    Mol Immunol; 2017 Nov; 91():49-56. PubMed ID: 28886586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
    Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
    J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.
    Zhang Y; Su SC; Hecox DB; Brady GF; Mackin KM; Clark AG; Foster MH
    J Immunol; 2008 Nov; 181(9):6092-100. PubMed ID: 18941198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease.
    Nishibata Y; Masuda S; Nakazawa D; Tanaka S; Tomaru U; Nergui M; Jia X; Cui Z; Zhao MH; Nakabayashi K; Ishizu A
    Exp Mol Pathol; 2019 Apr; 107():165-170. PubMed ID: 30817909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models.
    Worni-Schudel IM; Clark AG; Chien T; Hwang KK; Chen BJ; Foster MH
    J Transl Med; 2015 Jun; 13():185. PubMed ID: 26048777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
    Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
    J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
    Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
    J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
    Ryan JJ; Mason PJ; Pusey CD; Turner N
    Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.